Effect of Whey Protein Supplementation on Postoperative Outcomes After Gynecological Cancer Surgery: A Randomized Controlled Trial
World Journal of Oncology · 2025-02 · 16 (1) · 70-82
DOI: 10.14740/wjon1990 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift World Journal of Oncology, 2025-02. Verfasst von Wiranchana Chitti und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Rajavithi Hospital, Bangkok, Thailand. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Whey protein's biochemical properties make it an ideal nutritional supplement for patients with cancer, especially in perioperative care. Thus, the present study aims to assess the efficacy of whey protein supplementation (WPS) compared to standard care in enhancing postoperative outcomes for patients undergoing comprehensive surgical staging for gynecological cancer.
Methods
In an open-label, randomized controlled trial conducted at Rajavithi Hospital between November 28, 2023 and July 8, 2024, 61 patients scheduled for comprehensive surgical staging were enrolled. Participants were randomized in a 1:1 ratio to either the WPS group (n = 30) or the control group (n = 31). The WPS group received isolated whey protein powder (20 g of protein per serving), administered at 6 pm before surgery and 6 am on the first postoperative day. The control group received standard postoperative care. The primary endpoint was the length of hospital stay (LOHS), with secondary outcomes including gastrointestinal function recovery, postoperative analgesic use, complications, and potential WPS-related adverse events such as transaminitis, acute kidney injury, and electrolyte imbalances.
Results
The WPS group had a significantly shorter LOHS than the control group (79.0 ± 6.7 vs. 93.3 ± 28.4 h, P = 0.021). Additionally, the WPS group demonstrated significant improvements in gastrointestinal function, with shorter times to first flatus (P 0.05). Furthermore, no WPS-related adverse events were reported.
Conclusion
The use of WPS in the perioperative operative management of gynecological cancer surgery yields promising results by significantly reducing the LOHS and accelerating the recovery of gastrointestinal function while maintaining a favorable safety profile.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Rajavithi Hospital, Bangkok, Thailand.
- College of Medicine, Rangsit University, Bangkok, Thailand.
ORCID-Profile: Wiranchana Chitti, Putsarat Insin, Nisa Prueksaritanond
Zitieren
APA
Chitti, W., Insin, P., & Prueksaritanond, N. (2025). Effect of Whey Protein Supplementation on Postoperative Outcomes After Gynecological Cancer Surgery: A Randomized Controlled Trial. World Journal of Oncology, 16(1), 70-82. https://doi.org/10.14740/wjon1990
Vancouver
Chitti W, Insin P, Prueksaritanond N. Effect of Whey Protein Supplementation on Postoperative Outcomes After Gynecological Cancer Surgery: A Randomized Controlled Trial. World Journal of Oncology. 2025;16(1):70-82. doi:10.14740/wjon1990
BibTeX
@article{Chitti2025,
author = {Chitti, Wiranchana and Insin, Putsarat and Prueksaritanond, Nisa},
title = {Effect of Whey Protein Supplementation on Postoperative Outcomes After Gynecological Cancer Surgery: A Randomized Controlled Trial},
journal = {World Journal of Oncology},
year = {2025},
volume = {16},
number = {1},
pages = {70--82},
doi = {10.14740/wjon1990}
}
EUVIMED